Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil.
Epidermal growth factor (EGF) plays an important role in cancer. A functional single nucleotide polymorphism (SNP) in the 5'-untranslated region of the EGF gene (+61 A>G) may influence its expression and contribute to cancer predisposition and aggressiveness. Aiming to investigate the role of EGF +61 A>G in the susceptibility to glioma and its prognosis, we performed a case-control study with 165 patients and 200 healthy controls from Brazil. Comparisons of genotype distributions and allele frequencies did not reveal any significant differences between the groups. The mean overall survival was 9.2 months for A/A, 8.2 months for A/G, and 7.7 months for G/G. When survival curves were plotted we found that the +61G allele is associated with poor overall survival (p=0.023) but not with disease-free survival (p=0.527). Our data suggest that, although there is no association between the EGF +61 A>G genotype and glioma susceptibility, this SNP is associated with shorter overall survival of glioma patients in the Brazilian population. Nevertheless, future studies utilizing a larger series are essential for a definitive conclusion.
Pinto
Giovanni R
GR
Department of Biomedicine, Federal University of Piaui, Parnaiba, Brazil. pintogr@ufpi.edu.br
Yoshioka
France K N
FK
Clara
Carlos A
CA
Santos
Marcelo J
MJ
Almeida
José R W
JR
Burbano
Rommel R
RR
Rey
Juan A
JA
Casartelli
Calcida
C
D000328:Adult; D000368:Aged; D004815:Epidermal Growth Factor / Q000235:genetics* / Q000502:physiology; D005260:Female; D005838:Genotype; D005910:Glioma / Q000209:etiology / Q000235:genetics* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D012307:Risk Factors
D004815:Epidermal Growth Factor